Proliferative and anti-proliferative effects of titanium- and iron-based metallocene anti-cancer drugs

Journal of Organometallic Chemistry

Volumn 694, Issue 6, 2009, Pages 874-879

  Vessières, Anne ^a   Plamont, Marie Aude ^a   Cabestaing, Claude ^a   Claffey, James ^b   Dieckmann, Sandra ^b   Hogan, Megan ^b   Müller Bunz, Helge ^b   Strohfeldt, Katja ^b   Tacke, Matthias ^b  

^a PSL RESEARCH UNIVERSITY   (France)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Anti cancer drugs; Bioorganometallic chemistry; Breast cancer; Cisplatin; Ferrocene; Titanocene

Indexed keywords

BODY FLUIDS; CELL CULTURE; CHLORINE; CHLORINE COMPOUNDS; DERIVATIVES; IRON COMPOUNDS; ORGANOMETALLICS; PLATINUM COMPOUNDS; SINGLE CRYSTALS; TITANIUM; TITANIUM COMPOUNDS; YTTRIUM ALLOYS;

ANTI-CANCER DRUGS; BIOORGANOMETALLIC CHEMISTRY; BREAST CANCER; CISPLATIN; FERROCENE; TITANOCENE;

CYTOTOXICITY;

BOVINAE;

EID: 60749090546     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2008.11.071     Document Type: Article

References (48)

1. Schilling T., Keppler B.K., Heim M.E., Niebch G., Dietzfelbinger H., Rastetter J., and Hanauske A.R. Invest. New Drugs 13 (1996) 327
2. Caruso F., and Rossi M. Met. Ions Biol. Syst. 42 (2004) 353
3. Melendez E. Crit. Rev. Oncol. Hematol. 42 (2002) 309
4. Lummen G., Sperling H., Luboldt H., Otto T., and Rubben H. Cancer Chemother. Pharmacol. 42 (1998) 415
5. Kröger N., Kleeberg U.R., Mross K., Edler L., and Hossfeld D.K. Onkologie 23 (2000) 60
6. Allen O.R., Croll L., Gott A.L., Knox R.J., and McGowan P.C. Organometallics 23 (2004) 288
7. Causey P.W., Baird M.C., and Cole S.P.C. Organometallics 23 (2004) 4486
8. Meyer R., Brink S., van Rensburg C.E.J., Joone G.K., Gorls H., and Lotz S. J. Organomet. Chem. 690 (2005) 117
9. Fox S., Dunne J.P., Tacke M., and Gallagher J.F. Inorg. Chim. Acta 357 (2004) 225
10. Rehmann F.-J.K., Cuffe L.P., Mendoza O., Rai D.K., Sweeney N., Strohfeldt K., Gallagher W.M., and Tacke M. Appl. Organomet. Chem. 19 (2005) 293
11. Rehmann F.-J.K., Rous A.J., Mendoza O., Sweeney N.J., Strohfeldt K., Gallagher W.M., and Tacke M. Polyhedron 24 (2005) 1250
12. Tacke M., Allen L.T., Cuffe L., Gallagher W.M., Lou Y., Mendoza O., Müller-Bunz H., Rehmann F.J.K., and Sweeney N. J. Organomet. Chem. 689 (2004) 2242
13. Tacke M., Cuffe L.P., Gallagher W.M., Lou Y., Mendoza O., Müller-Bunz H., Rehmann F.-J.K., and Sweeney N. J. Inorg. Biochem. 98 (2004) 1987
14. Strohfeldt K., Müller-Bunz H., Pampillon C., Sweeney N.J., and Tacke M. Eur. J. Inorg. Chem. (2006) 4621
15. Sweeney N., Gallagher W.M., Müller-Bunz H., Pampillon C., Strohfeldt K., and Tacke M. J. Inorg. Biochem. 100 (2006) 1479
16. Sweeney N.J., Claffey J., Müller-Bunz H., Pampillon C., Strohfeldt K., and Tacke M. Appl. Organomet. Chem. 21 (2007) 57
17. Sweeney N.J., Mendoza O., Müller-Bunz H., Pampillon C., Rehmann F.-J.K., Strohfeldt K., and Tacke M. J. Organomet. Chem. 690 (2005) 4537
18. Hickey T., Claffey J., Fitzpatrick E., Hogan M., Pampillon C., and Tacke M. Invest. New Drugs 25 (2007) 425
19. Hogan M., Claffey J., Pampillon C., Watson R.W.G., and Tacke M. Organometallics 26 (2007) 2501
20. Pampillon C., Claffey J., Hogan M., Strohfeldt K., and Tacke M. Trans. Met. Chem. 32 (2007) 434
21. Pampillon C., Claffey J., Hogan M., and Tacke M. Z. Anorg. Allg. Chem. 633 (2007) 1695
22. Pampillon C., Claffey J., Hogan M., and Tacke M. BioMetals 21 (2008) 197
23. Pampillon C., Claffey J., Strohfeldt K., and Tacke M. Eur. J. Med. Chem. 43 (2008) 122
24. Pampillon C., Mendoza O., Sweeney N.J., Strohfeldt K., and Tacke M. Polyhedron 25 (2006) 2101
25. Pampillon C., Sweeney N.J., Strohfeldt K., and Tacke M. Inorg. Chim. Acta 359 (2006) 3969
26. Pampillon C., Sweeney N.J., Strohfeldt K., and Tacke M. J. Organomet. Chem. 692 (2007) 2153
27. Kelter G., Sweeney N.J., Strohfeldt K., Fiebig H.-H., and Tacke M. Anti-Cancer Drugs 16 (2005) 1091
28. Oberschmidt O., Hanauske A.-R., Rehmann F.-J.K., Strohfeldt K., Sweeney N., and Tacke M. Anti-Cancer Drugs 16 (2005) 1071
29. Oberschmidt O., Hanauske A.R., Pampillon C., Sweeney N.J., Strohfeldt K., and Tacke M. Anti-Cancer Drugs 18 (2007) 317
30. O'Connor K., Gill C., Tacke M., Rehmann F.-J.K., Strohfeldt K., Sweeney N., Fitzpatrick J.M., and Watson R.W.G. Apoptosis 11 (2006) 1205
31. Valadares M.C., Ramos A.L., Rehmann F.-J.K., Sweeney N.J., Strohfeldt K., Tacke M., and Queiroz M.L.S. Eur. J. Pharmacol. 534 (2006) 264
32. Beckhove P., Oberschmidt O., Hanauske A.R., Pampillon C., Schirrmacher V., Sweeney N.J., Strohfeldt K., and Tacke M. Anti-Cancer Drugs 18 (2007) 311
33. Fichtner I., Pampillon C., Sweeney N.J., Strohfeldt K., and Tacke M. Anti-Cancer Drugs 17 (2006) 333
34. Top S., Kaloun E.B., Vessières A., Laïos I., Leclercq G., and Jaouen G. J. Organomet. Chem. 643-644 (2002) 350
35. Timerbaev A.R., Hartinger C.G., Aleksenko S., and Keppler B.K. Chem. Rev. 106 (2006) 2224
36. Ravera M., Cassino C., Monti E., Gariboldi M., and Osella D. J. Inorg. Biochem. 99 (2005) 2264
37. Jaouen G., Top S., Vessières A., Leclercq G., and McGlinchey M.J. Curr. Med. Chem. 11 (2004) 2505
38. Jaouen G., Top S., Vessières A., Leclercq G., Quivy J., Jin L., and Croisy A. C.R. Acad. Sci. Paris Sér. IIc (2000) 89
39. Nguyen A., Vessieres A., Hillard E.A., Top S., Pigeon P., and Jaouen G. Chimia 61 (2007) 761
40. Top S., Vessières A., Leclercq G., Quivy J., Tang J., Vaissermann J., Huché M., and Jaouen G. Chem. Eur. J. 9 (2003) 5223
41. Vessières A., Top S., Pigeon P., Hillard E.A., Boubeker L., Spera D., and Jaouen G. J. Med. Chem. 48 (2005) 3937
42. HyperChem 7.0, Hypercube, Alberta, Canada, 2002.
43. Cense J.M. Phys. Theor. Chem. 71 (1990) 763
44. G.M. Sheldrick, University of Göttingen, Germany, 2002.
45. G.M. Sheldrick, University of Göttingen, Germany, 1997.
46. Bhattacharya A.A., Grune T., and Curry S. J. Mol. Biol. 303 (2000) 721
47. Hillard E.A., Vessières A., Thouin L., Jaouen G., and Amatore C. Angew. Chem., Int. Ed. 45 (2006) 285
48. Hillard E.A., Vessières A., Le Bideau F., Plazuk D., Spera D., Huché M., and Jaouen G. ChemMedChem 1 (2006) 551